Navigating Neuromuscular Blockade Reversal in Critical Care

This chapter examines the use of Sugammadex and neostigmine for reversing neuromuscular blockade in critically ill patients, particularly in a neuro ICU setting. The discussion contrasts the two agents, exploring their pharmacology, limitations, and implications for patient outcomes, especially post-cardiac surgery. It highlights the importance of understanding the complexities of drug administration and financial considerations in making informed therapeutic decisions.